James Pearson
Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heat Stress Disorders | 7 | 2023 | 76 | 2.800 |
Why?
| | Skin Temperature | 5 | 2024 | 30 | 2.430 |
Why?
| | Lower Body Negative Pressure | 7 | 2024 | 22 | 2.120 |
Why?
| | Hemorrhage | 6 | 2024 | 722 | 1.840 |
Why?
| | Arterial Pressure | 8 | 2024 | 126 | 1.810 |
Why?
| | Exercise | 11 | 2024 | 2057 | 1.490 |
Why?
| | Skin | 4 | 2024 | 752 | 1.440 |
Why?
| | Hemodynamics | 8 | 2020 | 1113 | 1.410 |
Why?
| | Cold Temperature | 3 | 2024 | 179 | 1.390 |
Why?
| | Heat-Shock Response | 7 | 2023 | 77 | 1.340 |
Why?
| | Body Temperature | 5 | 2017 | 222 | 1.080 |
Why?
| | Regional Blood Flow | 10 | 2018 | 474 | 0.920 |
Why?
| | Myocardium | 3 | 2020 | 1002 | 0.890 |
Why?
| | Fever | 6 | 2017 | 306 | 0.810 |
Why?
| | Sweating | 6 | 2017 | 40 | 0.810 |
Why?
| | Skin Transplantation | 3 | 2017 | 85 | 0.740 |
Why?
| | Hypoxia | 6 | 2016 | 1112 | 0.670 |
Why?
| | Sympathetic Nervous System | 3 | 2019 | 182 | 0.670 |
Why?
| | Equilibrative Nucleoside Transport Proteins | 1 | 2019 | 1 | 0.650 |
Why?
| | Microcirculation | 3 | 2016 | 149 | 0.650 |
Why?
| | Diastole | 2 | 2019 | 149 | 0.650 |
Why?
| | Hot Temperature | 4 | 2017 | 391 | 0.640 |
Why?
| | Exercise Tolerance | 2 | 2018 | 279 | 0.600 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2019 | 135 | 0.600 |
Why?
| | Dehydration | 4 | 2013 | 51 | 0.600 |
Why?
| | Cerebrovascular Circulation | 6 | 2020 | 243 | 0.590 |
Why?
| | Syncope | 4 | 2023 | 52 | 0.590 |
Why?
| | Burns | 4 | 2017 | 325 | 0.580 |
Why?
| | Serotonin | 1 | 2019 | 323 | 0.540 |
Why?
| | Reflex | 1 | 2017 | 68 | 0.530 |
Why?
| | Methacholine Chloride | 1 | 2017 | 52 | 0.530 |
Why?
| | Thermotolerance | 1 | 2017 | 9 | 0.530 |
Why?
| | Rest | 3 | 2013 | 121 | 0.510 |
Why?
| | Prediabetic State | 1 | 2019 | 253 | 0.510 |
Why?
| | Body Temperature Regulation | 7 | 2017 | 97 | 0.500 |
Why?
| | Oxidative Stress | 3 | 2019 | 1317 | 0.480 |
Why?
| | Central Nervous System | 1 | 2017 | 258 | 0.470 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 526 | 0.460 |
Why?
| | Endothelium, Vascular | 2 | 2019 | 927 | 0.460 |
Why?
| | Leg | 3 | 2013 | 236 | 0.450 |
Why?
| | Oxygen | 3 | 2015 | 931 | 0.430 |
Why?
| | Drosophila melanogaster | 1 | 2015 | 233 | 0.420 |
Why?
| | Rats, Wistar | 3 | 2019 | 455 | 0.400 |
Why?
| | Synchrotrons | 4 | 2020 | 13 | 0.400 |
Why?
| | Young Adult | 14 | 2024 | 13209 | 0.380 |
Why?
| | Male | 36 | 2024 | 67762 | 0.380 |
Why?
| | Blood Pressure | 5 | 2024 | 1786 | 0.360 |
Why?
| | Acetylcholine | 4 | 2020 | 185 | 0.350 |
Why?
| | Muscle Contraction | 2 | 2010 | 424 | 0.350 |
Why?
| | Blood Flow Velocity | 8 | 2017 | 413 | 0.330 |
Why?
| | Pulmonary Artery | 3 | 2014 | 1086 | 0.320 |
Why?
| | Coronary Artery Disease | 1 | 2016 | 698 | 0.320 |
Why?
| | Heart Rate | 4 | 2023 | 822 | 0.320 |
Why?
| | Inflammation | 2 | 2022 | 2837 | 0.310 |
Why?
| | Intestines | 1 | 2012 | 357 | 0.300 |
Why?
| | Oxygen Consumption | 4 | 2018 | 696 | 0.300 |
Why?
| | Adult | 20 | 2024 | 37929 | 0.280 |
Why?
| | Insulin Resistance | 1 | 2016 | 1208 | 0.280 |
Why?
| | Homeobox Protein Nkx-2.5 | 2 | 2017 | 6 | 0.260 |
Why?
| | Angiography | 5 | 2014 | 207 | 0.260 |
Why?
| | Muscle, Skeletal | 3 | 2011 | 1724 | 0.260 |
Why?
| | Ventricular Function, Left | 4 | 2016 | 534 | 0.250 |
Why?
| | Hyperthermia, Induced | 3 | 2017 | 116 | 0.250 |
Why?
| | Female | 23 | 2024 | 73304 | 0.250 |
Why?
| | Heart Defects, Congenital | 3 | 2018 | 842 | 0.240 |
Why?
| | Pressoreceptors | 2 | 2015 | 19 | 0.240 |
Why?
| | Heart | 3 | 2019 | 655 | 0.230 |
Why?
| | Vasodilation | 4 | 2019 | 499 | 0.230 |
Why?
| | Adenosine Triphosphate | 3 | 2013 | 491 | 0.230 |
Why?
| | Acclimatization | 2 | 2017 | 177 | 0.220 |
Why?
| | Animals | 18 | 2022 | 36940 | 0.210 |
Why?
| | Humans | 33 | 2024 | 137585 | 0.210 |
Why?
| | Vagus Nerve Stimulation | 2 | 2020 | 29 | 0.210 |
Why?
| | Heart Ventricles | 2 | 2019 | 788 | 0.200 |
Why?
| | Pulmonary Circulation | 3 | 2011 | 429 | 0.190 |
Why?
| | Rats | 5 | 2019 | 5647 | 0.180 |
Why?
| | Interleukin-13 | 1 | 2022 | 149 | 0.180 |
Why?
| | Afferent Pathways | 1 | 2020 | 45 | 0.170 |
Why?
| | Lung | 7 | 2022 | 4060 | 0.170 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 80 | 0.160 |
Why?
| | Disease Models, Animal | 4 | 2019 | 4295 | 0.160 |
Why?
| | Stroke Volume | 2 | 2015 | 612 | 0.160 |
Why?
| | Body Surface Area | 2 | 2017 | 34 | 0.160 |
Why?
| | Microdialysis | 1 | 2019 | 52 | 0.160 |
Why?
| | Connectin | 1 | 2019 | 33 | 0.160 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2019 | 18 | 0.160 |
Why?
| | Hydroxyindoleacetic Acid | 1 | 2019 | 26 | 0.160 |
Why?
| | Guanylate Cyclase | 1 | 2019 | 37 | 0.160 |
Why?
| | Time Factors | 7 | 2018 | 6828 | 0.160 |
Why?
| | Multienzyme Complexes | 1 | 2019 | 68 | 0.160 |
Why?
| | Bicycling | 2 | 2018 | 114 | 0.160 |
Why?
| | Myosins | 1 | 2019 | 135 | 0.150 |
Why?
| | Superoxides | 1 | 2019 | 202 | 0.150 |
Why?
| | Central Venous Pressure | 2 | 2015 | 14 | 0.150 |
Why?
| | Actin Cytoskeleton | 1 | 2019 | 103 | 0.150 |
Why?
| | Middle Cerebral Artery | 3 | 2013 | 53 | 0.150 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2019 | 204 | 0.150 |
Why?
| | Vagus Nerve | 1 | 2019 | 86 | 0.150 |
Why?
| | Quinolines | 1 | 2019 | 178 | 0.150 |
Why?
| | Hydrogen Peroxide | 1 | 2019 | 328 | 0.140 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2018 | 59 | 0.140 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2017 | 3556 | 0.130 |
Why?
| | Infusions, Subcutaneous | 1 | 2017 | 23 | 0.130 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2022 | 383 | 0.130 |
Why?
| | Renal Circulation | 1 | 2016 | 58 | 0.130 |
Why?
| | Brain | 3 | 2020 | 2668 | 0.130 |
Why?
| | Gases | 1 | 2016 | 48 | 0.130 |
Why?
| | ERG1 Potassium Channel | 1 | 2016 | 6 | 0.130 |
Why?
| | Urea | 1 | 2016 | 81 | 0.130 |
Why?
| | Pulse Wave Analysis | 1 | 2017 | 272 | 0.120 |
Why?
| | Nitric Oxide | 2 | 2019 | 915 | 0.120 |
Why?
| | Point Mutation | 1 | 2017 | 235 | 0.120 |
Why?
| | Survivors | 2 | 2017 | 493 | 0.120 |
Why?
| | Posture | 1 | 2017 | 185 | 0.120 |
Why?
| | Hyperventilation | 1 | 2015 | 10 | 0.120 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2015 | 31 | 0.120 |
Why?
| | Hyperemia | 1 | 2016 | 49 | 0.120 |
Why?
| | Iodine | 2 | 2014 | 27 | 0.120 |
Why?
| | Coronary Circulation | 1 | 2016 | 143 | 0.120 |
Why?
| | Homeostasis | 2 | 2017 | 621 | 0.120 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2018 | 382 | 0.120 |
Why?
| | Adaptation, Physiological | 2 | 2017 | 553 | 0.120 |
Why?
| | Reference Values | 1 | 2017 | 816 | 0.120 |
Why?
| | Wnt Signaling Pathway | 1 | 2017 | 192 | 0.120 |
Why?
| | Phosphorylation | 1 | 2019 | 1759 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 354 | 0.110 |
Why?
| | Metformin | 1 | 2018 | 331 | 0.110 |
Why?
| | Sweat | 1 | 2014 | 47 | 0.110 |
Why?
| | Ventilation-Perfusion Ratio | 1 | 2014 | 10 | 0.110 |
Why?
| | Injury Severity Score | 1 | 2017 | 522 | 0.110 |
Why?
| | Forearm | 1 | 2014 | 119 | 0.110 |
Why?
| | Arteries | 1 | 2016 | 269 | 0.110 |
Why?
| | Physical Fitness | 1 | 2015 | 209 | 0.110 |
Why?
| | Peptides | 1 | 2019 | 985 | 0.110 |
Why?
| | Adolescent | 4 | 2023 | 21513 | 0.100 |
Why?
| | Hypercapnia | 1 | 2013 | 53 | 0.100 |
Why?
| | Thermometers | 1 | 2012 | 8 | 0.100 |
Why?
| | Sweat Glands | 1 | 2012 | 4 | 0.100 |
Why?
| | Paper | 1 | 2012 | 10 | 0.100 |
Why?
| | Biological Evolution | 1 | 2016 | 474 | 0.100 |
Why?
| | Telemetry | 1 | 2012 | 40 | 0.090 |
Why?
| | Hot Flashes | 1 | 2013 | 87 | 0.090 |
Why?
| | Vascular Stiffness | 1 | 2017 | 494 | 0.090 |
Why?
| | Animals, Newborn | 1 | 2014 | 844 | 0.090 |
Why?
| | Chronic Disease | 2 | 2016 | 1793 | 0.090 |
Why?
| | Hemoglobins | 2 | 2012 | 353 | 0.090 |
Why?
| | Cytokines | 1 | 2019 | 2085 | 0.090 |
Why?
| | Cardiovascular System | 1 | 2013 | 137 | 0.090 |
Why?
| | Catheterization | 1 | 2012 | 179 | 0.090 |
Why?
| | Stress, Physiological | 1 | 2014 | 443 | 0.090 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2012 | 89 | 0.090 |
Why?
| | Water-Electrolyte Balance | 1 | 2010 | 34 | 0.090 |
Why?
| | Postmenopause | 1 | 2013 | 366 | 0.090 |
Why?
| | Diagnostic Tests, Routine | 1 | 2012 | 110 | 0.090 |
Why?
| | Oxyhemoglobins | 1 | 2010 | 23 | 0.090 |
Why?
| | Nitrites | 1 | 2010 | 84 | 0.080 |
Why?
| | rho-Associated Kinases | 1 | 2011 | 83 | 0.080 |
Why?
| | Epinephrine | 1 | 2010 | 139 | 0.080 |
Why?
| | Norepinephrine | 1 | 2010 | 204 | 0.080 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1291 | 0.080 |
Why?
| | Physical Exertion | 1 | 2010 | 215 | 0.080 |
Why?
| | Myocardial Contraction | 1 | 2010 | 341 | 0.080 |
Why?
| | Kidney | 1 | 2016 | 1468 | 0.070 |
Why?
| | Disease Progression | 1 | 2016 | 2757 | 0.070 |
Why?
| | Prognosis | 1 | 2017 | 4030 | 0.070 |
Why?
| | Benzofurans | 1 | 2008 | 21 | 0.070 |
Why?
| | Vasoconstriction | 4 | 2011 | 202 | 0.070 |
Why?
| | Antioxidants | 1 | 2011 | 584 | 0.070 |
Why?
| | Cardiac Output | 2 | 2018 | 165 | 0.070 |
Why?
| | Lower Extremity | 1 | 2010 | 427 | 0.060 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2008 | 137 | 0.060 |
Why?
| | Biomarkers | 3 | 2012 | 4149 | 0.060 |
Why?
| | Cognition | 1 | 2013 | 1153 | 0.060 |
Why?
| | Phenylephrine | 2 | 2015 | 75 | 0.060 |
Why?
| | Erythrocytes | 1 | 2010 | 700 | 0.060 |
Why?
| | Aging | 1 | 2015 | 1864 | 0.060 |
Why?
| | Dietary Supplements | 1 | 2008 | 561 | 0.050 |
Why?
| | Mice | 5 | 2022 | 17787 | 0.050 |
Why?
| | Pregnancy | 3 | 2022 | 6763 | 0.050 |
Why?
| | Middle Aged | 4 | 2017 | 33479 | 0.050 |
Why?
| | Hypertension, Pulmonary | 2 | 2011 | 1910 | 0.050 |
Why?
| | Fluid Therapy | 2 | 2012 | 147 | 0.040 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2020 | 47 | 0.040 |
Why?
| | Aged | 2 | 2017 | 23961 | 0.040 |
Why?
| | Perfusion | 1 | 2020 | 213 | 0.040 |
Why?
| | Rats, Inbred WKY | 1 | 2019 | 36 | 0.040 |
Why?
| | Vasodilator Agents | 2 | 2011 | 331 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2012 | 1316 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2017 | 15657 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 3 | 2011 | 2486 | 0.040 |
Why?
| | Sheep | 1 | 2020 | 856 | 0.030 |
Why?
| | Infant, Premature | 1 | 2022 | 574 | 0.030 |
Why?
| | Signal Transduction | 1 | 2011 | 5079 | 0.030 |
Why?
| | Muscles | 1 | 2018 | 326 | 0.030 |
Why?
| | Renal Veins | 1 | 2016 | 19 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 2016 | 77 | 0.030 |
Why?
| | Renal Artery | 1 | 2016 | 37 | 0.030 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 840 | 0.030 |
Why?
| | Partial Pressure | 1 | 2015 | 30 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 39 | 0.030 |
Why?
| | Ion Channels | 1 | 2016 | 133 | 0.030 |
Why?
| | Respiration | 1 | 2015 | 199 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2017 | 305 | 0.030 |
Why?
| | Systole | 1 | 2015 | 189 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5757 | 0.030 |
Why?
| | Lactic Acid | 1 | 2015 | 305 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2015 | 267 | 0.030 |
Why?
| | Pulmonary Veins | 1 | 2014 | 99 | 0.030 |
Why?
| | Rabbits | 1 | 2014 | 794 | 0.020 |
Why?
| | Plasma Volume | 1 | 2012 | 19 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 922 | 0.020 |
Why?
| | Isotonic Solutions | 1 | 2012 | 38 | 0.020 |
Why?
| | Cerebral Arteries | 1 | 2013 | 59 | 0.020 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2012 | 45 | 0.020 |
Why?
| | Hematocrit | 1 | 2012 | 96 | 0.020 |
Why?
| | Exercise Test | 1 | 2015 | 625 | 0.020 |
Why?
| | Isoprostanes | 1 | 2011 | 15 | 0.020 |
Why?
| | Glutathione Disulfide | 1 | 2011 | 33 | 0.020 |
Why?
| | Texas | 1 | 2012 | 244 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2017 | 2167 | 0.020 |
Why?
| | Echocardiography, Doppler, Pulsed | 1 | 2011 | 14 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2012 | 413 | 0.020 |
Why?
| | Drinking | 1 | 2011 | 42 | 0.020 |
Why?
| | Monocrotaline | 1 | 2011 | 28 | 0.020 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2011 | 28 | 0.020 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2011 | 48 | 0.020 |
Why?
| | Rotation | 1 | 2011 | 117 | 0.020 |
Why?
| | Nitroprusside | 1 | 2011 | 69 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 860 | 0.020 |
Why?
| | Memory, Short-Term | 1 | 2013 | 250 | 0.020 |
Why?
| | Torque | 1 | 2010 | 84 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2022 | 6079 | 0.020 |
Why?
| | Elastic Modulus | 1 | 2010 | 123 | 0.020 |
Why?
| | Hyperoxia | 1 | 2010 | 90 | 0.020 |
Why?
| | Glutathione | 1 | 2011 | 356 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 346 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3015 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3196 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 2008 | 10 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2008 | 90 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2008 | 90 | 0.020 |
Why?
| | Contrast Media | 1 | 2011 | 467 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2011 | 810 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2008 | 86 | 0.020 |
Why?
| | Propranolol | 1 | 2007 | 50 | 0.020 |
Why?
| | Arterioles | 1 | 2007 | 52 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2008 | 155 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 372 | 0.020 |
Why?
| | Body Weight | 1 | 2011 | 985 | 0.020 |
Why?
| | Iopamidol | 1 | 2006 | 17 | 0.020 |
Why?
| | Exercise Therapy | 1 | 2011 | 443 | 0.020 |
Why?
| | Drug Interactions | 1 | 2008 | 410 | 0.020 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2007 | 323 | 0.010 |
Why?
| | Blood Vessels | 1 | 2006 | 187 | 0.010 |
Why?
| | Liver Diseases | 1 | 2008 | 315 | 0.010 |
Why?
| | Mutation | 1 | 2016 | 3958 | 0.010 |
Why?
| | Kinetics | 1 | 2008 | 1670 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2012 | 3284 | 0.010 |
Why?
| | Models, Molecular | 1 | 2008 | 1570 | 0.010 |
Why?
| | Protein Binding | 1 | 2008 | 2224 | 0.010 |
Why?
| | Research Design | 1 | 2007 | 1139 | 0.010 |
Why?
| | Risk Factors | 1 | 2008 | 10388 | 0.010 |
Why?
|
|
Pearson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|